Article summary
In February 2026, major advances in psychedelic medicine included a rapid 25-minute DMT therapy showing strong results for depression, psilocybin moving closer to regulatory approval, growing evidence that ketamineβs benefits may not depend on the βtripβ, expanded FDA β¦ The post PSYCH NEWS β 18/02/26 appeared first on Chemical Collective.
Continue to the original publication for the complete article.